163 related articles for article (PubMed ID: 11895107)
21. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
22. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
[TBL] [Abstract][Full Text] [Related]
23. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
24. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
25. Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma.
Abe A; Kiriyama Y; Hirano M; Miura T; Kamiya H; Harashima H; Tokumitsu Y
Eur J Pharmacol; 2002 Feb; 436(1-2):7-13. PubMed ID: 11834241
[TBL] [Abstract][Full Text] [Related]
26. PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.
Elnemr A; Ohta T; Iwata K; Ninomia I; Fushida S; Nishimura G; Kitagawa H; Kayahara M; Yamamoto M; Terada T; Miwa K
Int J Oncol; 2000 Dec; 17(6):1157-64. PubMed ID: 11078801
[TBL] [Abstract][Full Text] [Related]
27. Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines.
Kato M; Nagaya T; Fujieda M; Saito K; Yoshida J; Seo H
Jpn J Cancer Res; 2002 Jun; 93(6):660-6. PubMed ID: 12079514
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Sharma C; Pradeep A; Pestell RG; Rana B
J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
[TBL] [Abstract][Full Text] [Related]
30. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
[TBL] [Abstract][Full Text] [Related]
32. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
33. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH
Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836
[TBL] [Abstract][Full Text] [Related]
34. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA
Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
[TBL] [Abstract][Full Text] [Related]
35. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
36. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.
Kitamura S; Miyazaki Y; Shinomura Y; Kondo S; Kanayama S; Matsuzawa Y
Jpn J Cancer Res; 1999 Jan; 90(1):75-80. PubMed ID: 10076568
[TBL] [Abstract][Full Text] [Related]
38. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
[TBL] [Abstract][Full Text] [Related]
39. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
Blumentrath J; Neye H; Verspohl EJ
Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARgamma in normal mouse skin keratinocytes.
He G; Thuillier P; Fischer SM
J Invest Dermatol; 2004 Dec; 123(6):1110-9. PubMed ID: 15610522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]